
|Articles|June 4, 2007
Latebreakers: OC approved for continuous use
A new birth control pill that is taken daily 365 days a year has received approval. The FDA gave Wyeth the go-ahead for Lybrel, a combination oral contraceptive (OC) that contains 90 mcg levonorgestrel and 20 mcg ethinyl estradiol.
Advertisement
Newsletter
Pharmacy practice is always changing. Stay ahead of the curve with the Drug Topics newsletter and get the latest drug information, industry trends, and patient care tips.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Drug Topics
1
Severe COVID-19 Increases Stroke Risk for Patients With Asthma
2
How Community Pharmacists Are Proactively Managing Patients’ Migraines | NCPA 2025
3
The Variety of Migraine Treatment Options Opens the Door for Pharmacy Services | NCPA 2025
4
Pharmacists Help Patients Stay Adherent to COPD Therapy, Improving Overall Quality of Life
5